D

Deerfield Partners

3 employees

Deerfield Partners is a real estate brokerage firm focused exclusively on the sale of newly built Walgreens investment properties.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology2
Biopharma1
Therapeutics1
cerebral adrenoleukodystrophy1
gene therapy1
sickle cell disease1
gene addition1
Genetics1
Health Diagnostics1
Pharmaceutical1
beta-thalassemia1

Funding rounds participated in

$28M sweet spot round size

Most of their 3 investments are in rounds between $21M and $28M

Investor type

Venture Capital

Basic info

Industry

leasing non-residential real estate

Sectors

Investments made

O

Ocera Therapeutics Inc raised $28M on November 6, 2013

Investors: Great Point Partners, Three Arch Partners, RA Capital Management, L.P., InterWest Partners, Venrock, QVT Financial LLP, Vivo Capital and Deerfield Partners

b

bluebird bio raised $60M on July 25, 2012

Investors: TVM Life Science Management Inc, RA Capital Management, L.P., Third Rock Ventures, Forbion, ARCH Venture Partners and Deerfield Partners

U

Undisclosed raised $21M on November 19, 2008

Investors: Safeguard Scientifics, HealthCap and Deerfield Partners

FAQ